<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Problems of Virology</journal-id><journal-title-group><journal-title xml:lang="en">Problems of Virology</journal-title><trans-title-group xml:lang="ru"><trans-title>Вопросы вирусологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0507-4088</issn><issn publication-format="electronic">2411-2097</issn><publisher><publisher-name xml:lang="en">Central Research Institute for Epidemiology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">11806</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">The key role of Asp'6 in the proteolysis of the NP protein of influenza A virus by caspases</article-title><trans-title-group xml:lang="ru"><trans-title>Ключевая роль Asp16 в протеолизе белка NP вируса гриппа А каспазами в инфицированных клетках</trans-title></trans-title-group></title-group><pub-date date-type="pub" iso-8601-date="2003-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2003</year></pub-date><volume>48</volume><issue>6</issue><issue-title xml:lang="en">NO6 (2003)</issue-title><issue-title xml:lang="ru">№6 (2003)</issue-title><fpage>8</fpage><lpage>14</lpage><history><date date-type="received" iso-8601-date="2023-06-09"><day>09</day><month>06</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2003, Zhirnov О.P., Vorobyova I.V., Veselovsky E.M., Klenk H.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2003, Жирнов О.П., Воробьева И.В., Веселовский Е.М., Klenk H.</copyright-statement><copyright-year>2003</copyright-year><copyright-holder xml:lang="en">Zhirnov О.P., Vorobyova I.V., Veselovsky E.M., Klenk H.</copyright-holder><copyright-holder xml:lang="ru">Жирнов О.П., Воробьева И.В., Веселовский Е.М., Klenk H.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://virusjour.crie.ru/jour/article/view/11806">https://virusjour.crie.ru/jour/article/view/11806</self-uri><abstract xml:lang="en"><p>The main nucleocapsid protein NP (molecular weight - 56 kD) of human influenza A virus (IAV) was found to be subject to the N-terminal proteolysis in position Asp16 with production of aNP (molecular weight - 53 kD) in the infected cells' apoptosis. It was assumed that NP of avian and animal influenza viruses was not subject to proteolysis since it has Gly'6. To verify the above assumption the NP chimeric gene of human influenza virus was developed; Asp16 was replaced by Gly by means of "site-oriented" mutagenesis in the above gene, after that, the A/ WSN/33 (H1N1) mutant of human influenza virus with "avian" NP and with point mutation (Gly16) was developed by using the method of "reverse genetics". The "human" influenza virus with "avian" chimeric NP/Gly16 turned out to be viable but had a lower replication velocity versus its wild-nature counterpart. It is noteworthy, that the mutant virus caused the cellular apoptosis in the remote infection period the way the wild virus did; however, NP of the former was found to be resistant to cellular caspasas and was not subject to proteolysis in infected cells. The conclusion is that Asp16 in NP molecule of human IAV is involved into the regulation process of virus replication and is the key element in NP proteolysis by cellular caspasas in cells' apoptosis.</p></abstract><trans-abstract xml:lang="ru"><p>Установлено, что при апоптозе инфицированных клеток главный нуклеокапсидный белок NP (мол. масса 56 кД) вируса гриппа А человека претерпевает N-концевой протеолиз в позиции Asp16 с образованием продукта aNP (мол. масса 53 кД). Предполагалось, что белок NP вирусов гриппа птиц и животных не подвержен протеолизу, так как имеет Gly16. Для проверки этого предположения получали химерный ген NP вируса гриппа человека, в котором посредством сайтнаправленного мутагенеза Asp16 заменен на Gly, и с помощью метода "обратной генетики" получен мутант вируса гриппа человека A/WSN/33 (H1N1), несущий NP "птичьего типа" с точечной мутацией (Gly16). Обнаружено, что вирус гриппа "человека" с химерным NP/Gly16 "птичьего типа" оказался жизнеспособным, но имел сниженную скорость репродукции по сравнению с диким вирусом. При этом, подобно дикому типу, мутантный вирус вызывал апоптоз клеток на поздних сроках инфекции, однако его белок NP был резистентным к клеточным каспазам и не подвергался протеолизу в инфицированных клетках. Из этих наблюдений следует, что Asp16 в молекуле NP вируса гриппа А человека участвует в регуляции репликации вируса и играет ключевую роль в протеолизе NP клеточными каспазами при апоптозе клеток.</p></trans-abstract><kwd-group xml:lang="en"><kwd>influenza A virus</kwd><kwd>nucleoprotein</kwd><kwd>reverse genetics</kwd><kwd>caspasas</kwd><kwd>proteolysis</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>вирус гриппа А</kwd><kwd>нуклеопротеин</kwd><kwd>обратная генетика</kwd><kwd>каспазы</kwd><kwd>пратеолиз</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Albo С., Valencia A., Portela A. Identification of an RNA binding region within the N-terminal third of the influenza A virus nucleoprotein // J. Virol. - 1995. - Vol. 69. - P. 3799-3806.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Avalos R. Т., Yu Z., Nayak D. P. Association of influenza virus NP and Ml proteins with cytosceletal elements in influenza virus-infected cells // Ibid. - 1997. - Vol. 71. - P. 2947-2958.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Barcena J., Ochoa M., de la Luna S. et al. Monoclonal antibodies against influenza virus PB2 and NP polypeptides interfere with the initiation step of viral mRNA synthesis in vitro // Ibid. - 1994. - Vol. 68. - P. 6900-6909.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Bean W. J. Correlation of influenza A virus nucleoprotein genes with host species // Virology. - 1984. - Vol. 133. - P. 438- 442.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Beaton A. R., Krug R. M. Transcription antitermination during influenza viral template RNA synthesis requires the nucleocapsid proteins and the absence of a 5' capped end // Proc. Natl. Acad. Sci. USA. - 1986. - Vol. 83. - P. 6282-6286. 1.	13</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Buckler-White A. J., Murphy В. R. Nucleotide sequence analysis of the nucleoprotein gene of an avian and a human influenza virus strain identifies two classes of nucleoproteins // Virology. - 1986. - Vol. 155. - P. 345-355.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Fodor E., Devenish L., Engelhard O. G. et al. Rescue of influenza A virus from recombinant DNA // J. Virol. - 1999. - Vol. 73. - P. 9679-9682.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Gammelin M., Mandler J., Scholtissek C. Two subtypes of nucleoprotein (NP) of influenza A viaises // Virology. - 1989. - Vol. 170. - P. 71-80.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Gorman О. Т., Bean W. J., Kawaoka Y., Webster R. G. Evolution of the nucleocapsid gene of influenza A virus // J. Virol. , - 1990. - Vol. .64. - P. 1487-1497.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Hirt B. Selective extraction of polyoma DNA from infected mouse cell cultures // J. Mol. Biol. - 1967. - Vol. 26. - P. 365-369.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Honda A., Veda K., Nagata K., Ishihama A. RNA polymerase of influenza virus: role of NP in RNA chain elongation // J. Biochem. - 1988. - Vol. 104. - P. 1021-1026.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Klenk H. D., Rott R., Orlich M., Blodorn J. Activation of influenza A viruses by trypsin treatment // Virology. - 1975. - Vol. 68. - P. 426-439.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Kobayashi M., Toyoda Т., Adyshev D. M. et al. Molecular dissection of influenza virus nucleoprotein: deletion mapping of the RNA binding-domain // J. Virol. - 1994. - Vol. 68. P. 8433-8436.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Kyhse-Anderson J. Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose // J. Biochem. Biophys. Meth. - 1984. - Vol. 10. - P. 203-209.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Lazarowitz.S. G., Choppin P. W. Enhancement of the infectivity of influenza A and В viruses by proteolytic cleavage of the hemagglutinin polypeptide // Virology. - 1975. - Vol. 68. - p. 440-454.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>McCauley J., Mahy B. W. J. Structure and function of influenza virus genome // Biochem. J. - 1985. - Vol. 211. - P. 281-294.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Momose F., Busier C. F., O'Neill R. E. et al. Cellular splicing factor RAF-2p48/NPI-5/BATl/UAP56 interacts with the influenza virus nucleoprotein and enhances viral RNA synthesis // J. Virol. - 2001. - Vol. 75. - P. 1899-1908.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Neumann G., Castrucci M. R., Kawaoka Y. Nuclear import and export of influenza virus nucleoprotein // Ibid. - 1997. - Vol. 71. - P. 9690-9700.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Neumann G., Watanabe Т., Ito H. et al. Generation of influenza A viruses entirely from cloned cDNAs // Proc. Natl. Acad. Sci. USA. - 1999. - Vol. 96. - P. 9345-9350.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Sanger F., Nicklen S., Coulson A. DNA sequencing with chainterminating inhibitors // Ibid. - 1977. - Vol. 74. - P. 5463- 5467.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Schulze I. The structure of influenza virus. 2. A model based on the morphology and composition of subviral particles // Virology. - 1972. - Vol. 47. - P. 181-196.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Shapiro G. L., Krug R. M. Influenza virus RNA replication in vitro: synthesis of viral template RNAs and virion RNAs in the absence of an added primer // J. Virol. - 1988. - Vol. 62. - P. 2285-2290.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Stennicke H. R., Salvesen G. S. Caspases-controlling intracellular signals by protease zymogene activation // Biochim. Biophys. Acta. - 2000. - Vol. 1477. - P. 299-306.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Talanian R. V., Quintan C., Trautz S. et al. Substrate specificity of caspase family proteases // J. Biol. Chem. - 1997. - Vol. 272. - P. 9677-9682.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Tian S. F., Buckler-White A. J., London W. T. et al. Nucleoprotein and membrane protein genes are associated with restriction of replication of influenza A/Mallard/NY/78 virus and its reassortants in squirrel monkey respiratory tract // J. Virol. - 1985. -Vol.53. -P. 771-775.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Wang P., Palese P., O'Neill R. E. The NPI-l/NPI-3 (karyopherin a) binding site on the influenza A virus nucleoprotein NP is a nonconventional nuclear localization signal // Ibid. - 1997. - Vol. 71. - P. 1850-1856.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Zhirnov O. P., Bukrinskaya A. G. Two forms of influenza virus nucleoprotein in infected cells and virions // Virology. - 1981. -Vol. 109. - P. 174-179.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Zhirnov O. P., Ovcharenko A. V., Bukrunskaya A. G. A modified plaque assay method for accurate analysis of infectivity of influenza viruses with uncleaved hemagglutinin // Arch. Virol. - 1982.-Vol. 71. - P. 177-183.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Zhirnov O. P., Bukrinskaya A. G. Nucleoprotein of animal influenza viruses, in contrast to those of human strains, are not cleaved in infected cells // J. Gen. Virol. - 1984. - Vol. 65. - P. 1127-1134.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Zhirnov O. P. The host origin of influenza viruses can be assessed by the intracellular cleavage of the viral nucleocapsid protein // Arch. Virol. - 1988. - Vol. 99. - P. 277-284.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Zhirnov O. P., Konakova T. E., Garten W., Klenk H. D. Caspase-dependent N-terminal cleavage of influenza virus nucleocapsid protein in infected cells // J. Virol. - 1999. - Vol. 73. - P. 10158-10163.</mixed-citation></ref></ref-list></back></article>
